Weil Company, Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weil Company, Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$149,000
-42.5%
33,235
-37.6%
0.07%
-48.1%
Q3 2021$259,000
-30.7%
53,235
-3.0%
0.14%
-28.6%
Q2 2021$374,000
-3.6%
54,9070.0%0.19%
-14.1%
Q1 2021$388,000
-40.9%
54,907
-47.7%
0.22%
-44.0%
Q4 2020$657,000
+16.5%
104,907
+0.7%
0.39%
-4.4%
Q3 2020$564,000
+100.7%
104,187
+93.8%
0.41%
+73.4%
Q2 2020$281,000
+208.8%
53,756
+86.9%
0.24%
+175.6%
Q1 2020$91,000
-5.2%
28,756
+21.1%
0.09%
+17.8%
Q4 2019$96,000
-99.9%
23,750
+18.8%
0.07%
+14.1%
Q3 2019$86,000,00020,0000.06%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders